647 filings
Page 15 of 33
S-1MEF
2pyypru5
8 Nov 17
Registration of additional securities for an S-1
12:00am
POS EX
k50 y0da5il69
8 Nov 17
Additional exhibits for listing
12:00am
EFFECT
ryvy5dlu7k4vtn8 ej
7 Nov 17
Notice of effectiveness
12:00am
S-1/A
63vgruvs lwvdl8xkhp
30 Oct 17
IPO registration (amended)
12:00am
CT ORDER
6ktszd8yiqg
30 Oct 17
Confidential treatment order
12:00am
8-K
1mztl
23 Oct 17
Vical Reports Third Quarter 2017 Financial and Operational Results
12:00am
S-1
bqwnb4 1sk
16 Oct 17
IPO registration
12:00am
8-K
44x1 gmls
2 Oct 17
Vical Announces that its Antifungal VL-2397 is Eligible for Limited Use Indication Approval by FDA Based on a Single Phase 2 Efficacy Trial
12:00am
S-8
cgozkqasf a8gvcmo3v
9 Aug 17
Registration of securities for employees
12:00am
8-K
2uvjlg
8 Aug 17
Vical Reports Second Quarter 2017 Financial and Operational Results
12:00am
8-K
nj42p8fc4faz
1 Jun 17
Departure of Directors or Certain Officers
12:00am
8-K
g32 0zlbvrozwu014bv
15 May 17
Vical Reports First Quarter 2017 Financial Results
12:00am
DEFA14A
ut4m78c7y e48j
7 Apr 17
Additional proxy soliciting materials
12:00am
8-K
lt3qn3at
4 Apr 17
Other Events
12:00am